Journal ID (nlm-ta): N Engl J Med
Journal ID (iso-abbrev): N Engl J Med
Journal ID (publisher-id): nejm
Title:
The New England Journal of Medicine
Publisher:
Massachusetts Medical Society
ISSN
(Print):
0028-4793
ISSN
(Electronic):
1533-4406
Publication date
(Print):
10
June
2021
Publication date PMC-release: 10
June
2021
Volume: 384
Issue: 23
Pages: 2259-2261
Affiliations
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD
Emory University School of Medicine, Decatur, GA
msuthar@
123456emory.edu
Emmes Company, Rockville, MD
Emory University School of Medicine, Decatur, GA
Kaiser Permanente Washington Health Research Institute, Seattle, WA
University of Maryland School of Medicine, Baltimore, MD
Emmes Company, Rockville, MD
Author notes
[*]
The mRNA-1273 Study Group members are listed in the
Supplementary Appendix, available with the full text of this letter at NEJM.org.
Drs. Doria-Rose and Suthar contributed equally to this letter.
Author information
Article
Publisher ID:
NJ202106103842317
DOI: 10.1056/NEJMc2103916
PMC ID: 8524784
PubMed ID: 33822494
SO-VID: 0fa667a2-040f-4f4c-8a49-392092b48329
Copyright © Copyright © 2021 Massachusetts Medical Society. All rights reserved.
License:
This article is made available via the PMC Open Access Subset for unrestricted re-use,
except commercial resale, and analyses in any form or by any means with acknowledgment
of the original source. These permissions are granted for the duration of the Covid-19
pandemic or until revoked in writing. Upon expiration of these permissions, PMC is
granted a license to make this article available via PMC and Europe PMC, subject to
existing copyright protections.
Funded by:
Covid-Catalyst-I3 Funds from the Woodruff Health Sciences Center and Emory School
of Medicine, FundRef http://dx.doi.org/10.13039/100006939;
Funded by:
North Carolina Policy Collaboratory at the University of North Carolina at Chapel
Hill, FundRef http://dx.doi.org/10.13039/100007890;
Funded by:
North Carolina Coronavirus Relief Fund, FundRef ;
Funded by:
Coalition for Epidemic Preparedness Innovations, FundRef http://dx.doi.org/10.13039/100016302;
Funded by:
Georgia Research Alliance, FundRef http://dx.doi.org/10.13039/100008065;
Funded by:
National Institute of Allergy and Infectious Diseases, FundRef http://dx.doi.org/10.13039/100000060;
Award ID: AI149644
Award ID: HHSN272201500002C
Award ID: P51 OD011132
Award ID: UM1AI148373
Award ID: UM1AI148576
Award ID: UM1AI148684
Award ID: UM1Al148684-01S1
Funded by:
National Center for Advancing Translational Sciences, FundRef http://dx.doi.org/10.13039/100006108;
Award ID: UL1 TR002243
Funded by:
Dolly Parton COVID-19 Research Fund, FundRef http://dx.doi.org/10.13039/100006537;
Funded by:
Emory Executive Vice President for Health Affairs Synergy Fund award, FundRef http://dx.doi.org/10.13039/100006939;
Funded by:
Center for Childhood Infections and Vaccines, FundRef http://dx.doi.org/10.13039/100006939;
Funded by:
Children’s Healthcare of Atlanta, FundRef ;